Chambal Fertilisers and Chemicals (CHAMBLFERT) Q2 26/27 earnings summary

Executive summary

• Q2 FY27 revenue from operations rose 9% YoY to ₹6,999.46 crore; standalone profit rose, while consolidated profit declined YoY.

• H1 FY27 revenue was ₹12,026.48 crore; EBITDA grew 9% to ₹1,751.6 crore, while consolidated profit fell 4% to ₹1,155.52 crore and standalone profit rose 8% to ₹1,338.44 crore.

• TAN commercial production began in August 2026; operating performance faced elevated input costs, uneven monsoon conditions and working-capital pressure.

Financial highlights

• Q2 revenue from operations was ₹6,999.46 crore vs ₹6,412.76 crore YoY; standalone EBITDA was ₹901 crore and standalone profit ₹634.95 crore.

• Consolidated Q2 profit was ₹523.60 crore vs ₹648.75 crore YoY; EPS was ₹15.77 vs ₹16.19.

• H1 revenue was ₹12,026.48 crore vs ₹12,110.37 crore; consolidated EBITDA grew 9% to ₹1,751.6 crore, with margin at 14.56% vs 13.23%.

• H1 consolidated profit declined 4% to ₹1,155.52 crore; standalone profit rose 8% to ₹1,338.44 crore.

Outlook and guidance

• Q3 EBITDA margins are expected to be maintained; Q4 visibility depends on geopolitical developments and operating conditions.

• Rabi fertiliser stocks and imports were positioned prudently; complex fertiliser margins are expected to be similar, though not necessarily identical.

• A potential new urea plant remains subject to Department of Fertilisers and Board approvals, project economics and environmental clearance; preparatory work is progressing.

• Five biological products are planned for FY28-29 and five for FY30-31; registration data generation for the initial five has begun.